These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17613431)

  • 21. TRAIL and cancer therapy.
    Kruyt FA
    Cancer Lett; 2008 May; 263(1):14-25. PubMed ID: 18329793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The TRAIL apoptotic pathway in cancer onset, progression and therapy.
    Johnstone RW; Frew AJ; Smyth MJ
    Nat Rev Cancer; 2008 Oct; 8(10):782-98. PubMed ID: 18813321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Lee TJ; Um HJ; Min do S; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2009 Jun; 46(12):1639-49. PubMed ID: 19345731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mcl-1: a gateway to TRAIL sensitization.
    Kim SH; Ricci MS; El-Deiry WS
    Cancer Res; 2008 Apr; 68(7):2062-4. PubMed ID: 18381408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a role for nuclear factor kappaB in tumor necrosis factor-related apoptosis-inducing ligand resistance?
    Plantivaux A; Szegezdi E; Samali A; Egan L
    Ann N Y Acad Sci; 2009 Aug; 1171():38-49. PubMed ID: 19723036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
    J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
    J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
    Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA
    Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRAIL induces MMP-9 expression via ERK activation in human astrocytoma cells.
    Kim JH; Choi C; Benveniste EN; Kwon D
    Biochem Biophys Res Commun; 2008 Dec; 377(1):195-9. PubMed ID: 18834856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).
    Ashkenazi A; Holland P; Eckhardt SG
    J Clin Oncol; 2008 Jul; 26(21):3621-30. PubMed ID: 18640940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid sensitizes K562 erythroleukemia cells to TRAIL/Apo2L-induced apoptosis.
    Iacomino G; Medici MC; Russo GL
    Anticancer Res; 2008; 28(2A):855-64. PubMed ID: 18507029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
    Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
    Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
    Zhang X; Li W; Olumi AF
    Clin Cancer Res; 2007 Dec; 13(23):7181-90. PubMed ID: 18056199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
    Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
    J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
    Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
    Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
    Ricci MS; Kim SH; Ogi K; Plastaras JP; Ling J; Wang W; Jin Z; Liu YY; Dicker DT; Chiao PJ; Flaherty KT; Smith CD; El-Deiry WS
    Cancer Cell; 2007 Jul; 12(1):66-80. PubMed ID: 17613437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.
    Zhou DH; Trauzold A; Röder C; Pan G; Zheng C; Kalthoff H
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):201-9. PubMed ID: 18397859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
    Ohtsuki T; Kikuchi H; Koyano T; Kowithayakorn T; Sakai T; Ishibashi M
    Bioorg Med Chem; 2009 Sep; 17(18):6748-54. PubMed ID: 19682913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.